Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference
24 May 2024 - 6:05AM
Business Wire
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA
and genetic testing, today announced that members of Natera’s
management will present at the 2024 Leerink Partners Healthcare
Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT
(11:40 a.m. ET).
A live webcast may be accessed through the investor relations
section of the Natera website at investor.natera.com. A replay of
the event will be available shortly following the conference.
About Natera
Natera™ is a global leader in cell-free DNA and genetic testing,
dedicated to oncology, women’s health, and organ health. We aim to
make personalized genetic testing and diagnostics part of the
standard-of-care to protect health and inform earlier, more
targeted interventions that help lead to longer, healthier lives.
Natera’s tests are supported by more than 200 peer-reviewed
publications that demonstrate excellent performance. Natera
operates ISO 13485-certified and CAP-accredited laboratories
certified under the Clinical Laboratory Improvement Amendments
(CLIA) in Austin, Texas, and San Carlos, California. For more
information, visit www.natera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240523245752/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc.,
510-405-4709, investor@natera.com Media: Lesley Bogdanow, VP of
Corporate Communications, Natera, Inc., pr@natera.com
Natera (NASDAQ:NTRA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Natera (NASDAQ:NTRA)
Historical Stock Chart
From Sep 2023 to Sep 2024